Lilly is the second drugmaker this week to go to court over the issue, a sign that the pharmaceutical industry is so fed up with the drug discounts that it is trying to overhaul them.

Eli Lilly and Company (NYSE: LLY) announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide.

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

OTT services have become the preferred choice for modern moviegoers. This article features a list of Tamil movies, Web series, and dubbed films that regularly debut on OTT platforms such as Amazon ...

OTT services have become the preferred choice for modern moviegoers. This article features a list of Tamil movies, Web series, and dubbed films that regularly debut on OTT platforms such as Amazon ...